# Dr. Bruce G. Rankin, DO – FDA Inspection, Sep 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/fa7388fb-83c0-415e-ac47-352c64837f6a
Source feed: FDA_Inspections

> FDA inspection 1218367 of Dr. Bruce G. Rankin, DO, September 22, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218367
- Company Name: Dr. Bruce G. Rankin, DO
- Inspection Date: 2023-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1133732 - 2020-11-24
- [FDA Inspection 927571 - 2015-05-08](https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/04a03367-8ee7-46d3-ae50-ed3ecbc6fc94)
- FDA Inspection 867756 - 2014-02-25
- FDA Inspection 642563 - 2010-01-26
- [FDA Inspection 646078 - 2010-01-12](https://www.keypedia.com/records/fda_inspections/dr-bruce-g-rankin-do/12a208d9-8b16-4284-9c95-abc930c5b10b)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)

Company: https://www.keypedia.com/companies/dr-bruce-g-rankin-do/e17db3fc-0266-4df0-9179-eb664fb264cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
